Clinical Trial Detail

NCT ID NCT03926143
Title A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies
Recruitment Enrolling by invitation
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications

cancer

Therapies

Anetumab ravtansine

Age Groups: adult senior

No variant requirements are available.